Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Abstract
Purpose To report the biologic effect of intravitreal bevacizumab in patients with retinal and iris neovascularization secondary to diabetes mellitus. Design Interventional, consecutive, retrospective, case series. Participants Forty-five eyes of 32 patients with retinal and/or iris neovascularization secondary to diabetes mellitus. Methods Patients received intravitreal bevacizumab (6.2 μg–1.25 mg). Ophthalmic evaluations included...
Paper Details
Title
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Published Date
Oct 1, 2006
Journal
Volume
113
Issue
10
Pages
1695 - 1705.e6
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History